north bergen.new jersey 3/26/2010 4:02:45 AM
News / Business

Interleukin Genetics Inc. Announces Fourth Quarter Conference call

Top Penny Stock Newsletter Presents to its Viewers, Interleukin Genetics Conference Call date to discuss its 4Q Earnings.

Interleukin Genetics, Inc. announced today that it will host a conference call and Webcast on Thursday, March 25, 2010 at 4:30 p.m. ET to discuss the Company's fourth quarter and year end 2009 financial results. Interleukin Genetics Inc. trades on the “American Stock Exchange” under the stock symbol “ILI”. For More information regarding the “ILI", make sure to visit the Most Exclusive and In Depth newsletter website at:   http://www.wallstreetgrand.com/.

 

 

Join today and be part of the best free investment newsletter on the web where we focus on market moving news.

Interleukin Genetics, Inc. (Amex: ILI) announced today that it will host a conference call and Webcast on Thursday, March 25, 2010 at 4:30 p.m. ET to discuss the Company's fourth quarter and year end 2009 financial results.

To access the live call, dial 877-324-1976 (domestic) or 631-291-4550 (international). The live Webcast and replay access of the teleconference will be available on the Investor's section of Interleukin Genetics, Inc.'s Website at http://www.ilgenetics.com/.

About Interleukin Genetics, Inc:

Interleukin Genetics, Inc. (Amex: ILI) develops and markets genetic tests that empower consumers to prevent chronic diseases and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics markets a line of genetic tests under the Inherent Health brand including Bone Health, Weight Management, Heart Health and Nutritional Needs

 

 

 

You can contact us during market hours at 1-888-9-ClubGrand (1888-925-8247) or via email at staff@wallstreetgrand.com.

 

 

 

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") including 2009 growth, revenue for the second quarter and year of 2009 and gross margin for the second quarter and year of 2009. Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the impact of intense competition, the continuation or worsening of current economic conditions and the condition of the domestic and global credit and capital markets.

 

 

Disclaimer:

 

Wall Street Grand LLC has not been compensated by the company for this press release and does not expect to be compensated in the future for any type of awareness. To read our full disclaimer clicks the link http://www.wallstreetgrand.com/disclosure.html